BioSpace News Archive

PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference

PharmAbcine Inc. announced today that the company is invited to deliver a video presentation at H.C Wainwright Ophthalmology Virtual Conference on August 17, 2021 .

July 26, 2021
·
3 min read
Business

PixCell Medical and Gamidor Diagnostics Partner to Introduce Point-of-Care Hematology Analysis in Israel

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced it has signed an exclusive distribution agreement with medical diagnostics company Gamidor Diagnostics to distribute the HemoScreen™, PixCell’s hematology analyzer, across Israel.

July 26, 2021
·
4 min read
Business

INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021

INOVIO (NASDAQ: INO) announced today that second quarter 2021 financial results will be released after the market close on August 9, 2021.

July 26, 2021
·
4 min read
Lone Star Bio

InGeneron Reports First-In-Human Microscopic Evidence of Adult Tendon Regeneration Following Autologous Stem Cell Treatment

InGeneron, Inc. today announced the publication of the first-in-human comprehensive immunohistochemical evaluation of adult tendon repair following the local injection of fresh, uncultured, unmodified, utologous, adipose derived regenerative cells (UA-ADRCs).

July 26, 2021
·
4 min read
Business

Invacare Corporation to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results

Invacare Corporation announces that it will release its financial results for the second quarter 2021, after the market closes on Wednesday, August 4, 2021.

July 26, 2021
·
2 min read
Genetown

Sesen Bio Announces Significant Commercial Progress as the Company Approaches the Potential Approval and Launch of Vicineum™ in the US

Sesen Bio today announced that it has completed its commercial build phase in preparation for the anticipated launch of Vicineum, if approved, in the US, and has advanced to the implementation phase that will focus on executing the Company’s commercial strategy for Vicineum.

July 26, 2021
·
8 min read
Genetown

New CDC Guidelines Endorse Opt-Out Screening for Two of the Most Common Sexually Transmitted Infections (STIs), Recommend Nucleic Acid Testing for Mycoplasma Genitalium

Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to screening for Chlamydia trachomatis and Neisseria gonorrhoea, two of the most common sexually transmitted infections (STIs) in the country.

July 26, 2021
·
8 min read
BiomX Inc. Announces $15 Million Registered Direct Offering

The securities are being sold at an offering price of $4.00 per share of the Company’s common stock and an accompanying warrant to purchase 0.75 of a share of the Company’s common stock at an exercise price of $5.00 per share.

July 26, 2021
·
4 min read
Drug Development

Basilea’s partner Asahi Kasei Pharma prepares NDA filing for the marketing authorization of isavuconazole in Japan based on positive phase 3 study results

Basilea Pharmaceutica Ltd. reported that its partner Asahi Kasei Pharma Corporation is planning to file a New Drug Application for the marketing authorization of the antifungal isavuconazole in Japan, based on the positive results of the recently completed phase 3 study in deep-seated mycoses.

July 26, 2021
·
4 min read
Santen and IAPB Taking Action to Implement the First Ever UN General Assembly Resolution Recognizing the Link Between Eye Health and Sustainable Development

Santen Pharmaceutical Co., Ltd. announced that Santen, in partnership with the International Agency for the Prevention of Blindness, will take action to implement United Nations General Assembly Resolution A/75/L.108 on eye health.

July 26, 2021
·
4 min read